Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice

Journal of Neuroscience Methods

Volumn 239, Issue , 2015, Pages 100-107

  Yu, Cheng Long ^a,b   Zhou, Heng ^a,b   Chai, An Ping ^b   Yang, Yue Xiong ^b   Mao, Rong Rong ^b   Xu, Lin ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Freely moving mice; Neurobehavioral assessments; Nimodipine; Photothrombotic ischemia

Indexed keywords

NIMODIPINE; ROSE BENGAL; TRIPHENYLTETRAZOLIUM; ANTINEOPLASTIC AGENT; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY EQUILIBRIUM; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; ENDURANCE; MOTOR COORDINATION; MOUSE; NONHUMAN; PHOTOTHROMBOTIC ISCHEMIA; PRIMARY MOTOR CORTEX; ROTAROD TEST; THROMBOSIS; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANIMAL; BRAIN INFARCTION; COMPLICATION; DISEASE MODEL; EXERCISE TEST; INBRED MOUSE STRAIN; INTRACRANIAL THROMBOSIS; LASER; LOCOMOTION; MALE; MOVEMENT DISORDERS; PHYSIOLOGY; WAKEFULNESS;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ETOPOSIDE; EXERCISE TEST; IFOSFAMIDE; INTRACRANIAL THROMBOSIS; LASERS; LOCOMOTION; MALE; METHOTREXATE; MICE; MICE, INBRED STRAINS; MOVEMENT DISORDERS; ROTAROD PERFORMANCE TEST; WAKEFULNESS;

EID: 84908432802     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2014.10.004     Document Type: Article

References (45)

1. Balkaya M., Kröber J., Gertz K., Peruzzaro S., Endres M. Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods 2013, 213:179-187.
2. Barth A.M.I., Mody I. Changes in hippocampal neuronal activity during and after unilateral selective hippocampal ischemia in vivo. J Neurosci 2011, 31:851-860.
3. Beltran E.J., Papadopoulos C.M., Tsai S.-Y., Kartje G.L., Wolf W.A. Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole. Brain Res 2010, 1346:174-182.
4. Biller J., Love B.B., Marsh E.E., Jones M.P., Knepper L.E., Jiang D., et al. Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke 1990, 21:1008-1012.
5. Buitrago M.M., Schulz J.B., Dichgans J., Luft A.R. Short and long-term motor skill learning in an accelerated rotarod training paradigm. Neurobiol Learn Mem 2004, 81:211-216.
6. Carmichael S.T. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005, 2:396-409.
7. Choi B.I., Park D., Lee S.H., Bae D.K., Yang G., Yang Y.H., et al. Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models. Environ Toxicol Pharmacol 2012, 33:60-69.
8. Dietrich W.D., Danton G., Hopkins A.C., Prado R., Prado R. Thromboembolic events predispose the brain to widespread cerebral infarction after delayed transient global ischemia in rats editorial comment. Stroke 1999, 30:855-862.
9. Dirnagl U. Rodent models of stroke 2010, Humana Press, c/o Springer, Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA.
10. Elwan O., Hashem S., Helmy A.A., el Tamawy M., Abdel Naseer M., Elwan F., et al. Cognitive deficits in ischemic strokes: psychometric, electrophysiological and cranial tomographic assessment. J Neurol Sci 1994, 125:168-174.
11. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J.P., et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008, 25:268-278.
12. Farr T.D., Liu L., Colwell K.L., Whishaw I.Q., Metz G.A. Bilateral alteration in stepping pattern after unilateral motor cortex injury: a new test strategy for analysis of skilled limb movements in neurological mouse models. J Neurosci Methods 2006, 153:104-113.
13. Freeman K., Colon-Rivera C., Olsson M.C., Moore R.L., Weinberger H.D., Grupp I.L., et al. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am J Physiol Heart C 2001, 280:H151-H159.
14. Fueger P.T., Shearer J., Krueger T.M., Posey K.A., Bracy D.P., Heikkinen S., et al. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. J Physiol Lond 2005, 566:533-541.
15. Germano I.M., Bartkowski H.M., Cassel M.E., Pitts L.H. The therapeutic value of nimodipine in experimental focal cerebral-ischemia - neurological outcome and histopathological findings. J Neurosurg 1987, 67:81-87.
16. Hines D.J., Haydon P.G. Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke. J Neurosci 2013, 33:4234-4240.
17. Hu A.H. The enzymatic activity of secondary organs during splanchnic ischemia-reperfusion 2008, UC, San Diego, b6636038, Retrieved from: https://escholarship.org/uc/item/98j565d6.
18. Isayama K., Pitts L.H., Nishimura M.C. Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat-brain infarcts. Stroke 1991, 22:1394-1398.
19. Jia Q., Zhao X., Wang C., Wang Y., Yan Y., Li H., et al. Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke 2011, 42:2758-2762.
20. Jiwa N.S., Garrard P., Hainsworth A.H. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 2010, 115:814-828.
21. Jones B.J., Roberts D.J. Quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 1968, 20:302-304.
22. Jueptner M., Frith C.D., Brooks D.J., Frackowiak R.S.J., Passingham R.E. Anatomy of motor learning .2. Subcortical structures and learning by trial and error. J Neurophysiol 1997, 77:1325-1337.
23. Kapinya K.J., Prass K., Dirnagl U. Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism?. Neuroreport 2002, 13:1431-1435.
24. Kim Y.K., Leem J.G., Shin J.W., Joung K.W. Ischemic postconditioning may not influence early brain injury induced by focal cerebral ischemia/reperfusion in rats. Korean J Anesthesiol 2010, 58:176-183.
25. Kuroiwa T., Xi G., Hua Y., Nagaraja T.N., Fenstermacher J.D., Keep R.F. Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen. Stroke 2009, 40:248-253.
26. Lee J.K., Park M.S., Kim Y.S., Moon K.S., Joo S.P., Kim T.S., et al. Photochemically induced cerebral ischemia in a mouse model. Surg Neurol 2007, 67:620-625.
27. Li H.B., Mao R.R., Zhang J.C., Yang Y., Cao J., Xu L. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 2008, 64:286-292.
28. Minetti G.C., Colussi C., Adami R., Serra C., Mozzetta C., Parente V., et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006, 12:1147-1150.
29. Nowicka D., Rogozinska K., Aleksy M., Witte O.W., Skangiel-Kramska J. Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain. Acta Neurobiol Exp 2008, 68:155-168.
30. Oyagi A., Hara H. Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain. CNS Neurosci Ther 2012, 18:803-810.
31. Pagala M.K., Ravindran K., Namba T., Grob D. Skeletal muscle fatigue and physical endurance of young and old mice. Muscle Nerve 1998, 21:1729-1739.
32. Papadopoulos C.M., Tsai S.-Y., Guillen V., Ortega J., Kartje G.L., Wolf W.A., et al. Axonal plasticity with short-term amphetamine after stroke. Stroke 2009, 40:294-302.
33. Peng T., Britton G.L., Kim H., Cattano D., Aronowski J., Grotta J., et al. Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. CNS Neurosci Ther 2013, 19:773-784.
34. Riahi F., Zijdenbos A., Narayanan S., Arnold D., Francis G., Antel J., et al. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods. Brain 1998, 121:1305-1312.
35. Rustay N.R., Wahlsten D., Crabbe J.C. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 2003, 141:237-249.
36. Saab B.J., Maclean A.J., Kanisek M., Zurek A.A., Martin L.J., Roder J.C., et al. Short-term memory impairment after isoflurane in mice is prevented by the alpha5 gamma-aminobutyric acid type A receptor inverse agonist L-655,708. Anesthesiology 2010, 113:1061-1071.
37. Saver J.L., Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke 2012, 43:1537-1541.
38. Shiotsuki H., Yoshimi K., Shimo Y., Funayama M., Takamatsu Y., Ikeda K., et al. A rotarod test for evaluation of motor skill learning. J Neurosci Methods 2010, 189:180-185.
39. Tatemichi T.K., Desmond D.W., Stem Y., Paik M., Sano M., Bagiella E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994, 57:202-207.
40. Veizovic T., Beech J.S., Stroemer R.P., Watson W.P., Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 2001, 32:1012-1019.
41. Wang Y., Wu D., Wang Y., Ma R., Wang C., Zhao W. A survey on adherence to secondary ischemic stroke prevention. Neurol Res 2006, 28:16-20.
42. Wang J., Feng X., Du Y., Wang L., Zhang S. Combination treatment with progesterone and rehabilitation training further promotes behavioral recovery after acute ischemic stroke in mice. Restor Neurol Neurosci 2013, 31:487-499.
43. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985, 17:497-504.
44. Yang L., Zhang Z., Sun D., Xu Z., Yuan Y., Zhang X., et al. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry 2011, 26:495-502.
45. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., Steinberg G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 2003, 85:1026-1036.